BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25242396)

  • 1. Deceptively benign appearing urothelial carcinoma.
    Humphrey PA
    J Urol; 2014 Dec; 192(6):1817-8. PubMed ID: 25242396
    [No Abstract]   [Full Text] [Related]  

  • 2. Micropapillary urothelial carcinoma of the urinary tract.
    Humphrey PA
    J Urol; 2011 Sep; 186(3):1071-2. PubMed ID: 21784465
    [No Abstract]   [Full Text] [Related]  

  • 3. Urothelial carcinoma of the upper urinary tract.
    Humphrey PA
    J Urol; 2014 Oct; 192(4):1223-4. PubMed ID: 25046603
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fundamental bases of urothelial carcinogenesis].
    Chopin D; Cappellen D; Fradvanyi F; Gattegno B
    Prog Urol; 2001 Nov; 11(5):879-924. PubMed ID: 11769084
    [No Abstract]   [Full Text] [Related]  

  • 5. [New proposal of histologic grading of non-invasive papillary urothelial tumor].
    Cheng L; Zhao M
    Zhonghua Bing Li Xue Za Zhi; 2014 Dec; 43(12):848-52. PubMed ID: 25623989
    [No Abstract]   [Full Text] [Related]  

  • 6. Surgical consolidation of initially unresectable urothelial carcinoma: an incremental opportunity to cure.
    Siefker-Radtke AO
    Expert Rev Anticancer Ther; 2009 Dec; 9(12):1701-3. PubMed ID: 19954279
    [No Abstract]   [Full Text] [Related]  

  • 7. The significance of prostatic urothelial dysplasia.
    Bryan RL; Newman J; Suarez V; Kadow C; O'Brien JM
    Histopathology; 1993 May; 22(5):501-3. PubMed ID: 8344661
    [No Abstract]   [Full Text] [Related]  

  • 8. The modern management of upper urinary tract urothelial cancer: tumour diagnosis, grading and staging.
    Painter DJ; Timoney AG; Denton K; Alken P; Keeley FX
    BJU Int; 2007 May; 99(5):973-7. PubMed ID: 17437428
    [No Abstract]   [Full Text] [Related]  

  • 9. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidermoid carcinoma of the urinary tract. Immunohistochemical study].
    Salas Valien JS; García Díez F; González Morán MA; Rodríguez López JA; Guerreiro González R
    Arch Esp Urol; 1990; 43(9):973-6. PubMed ID: 1708980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery.
    Chung SD; Lai MK; Chueh SC
    BJU Int; 2008 Aug; 102(4):519. PubMed ID: 18699962
    [No Abstract]   [Full Text] [Related]  

  • 12. [PPA (cis-platinum), peplomycin and adriamycin) combination chemotherapy in transitional cell carcinoma of the urothelial tract--pilot study].
    Ono Y; Ohshima S; Fujita T; Naide Y; Suzuki K; Asoh Y; Fukushima M; Ohta K
    Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):28-33. PubMed ID: 2422307
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial Comment to Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi-institutional study.
    Mitsui Y
    Int J Urol; 2015 Jul; 22(7):643-4. PubMed ID: 25903446
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tumor markers in the histopathology of urologic tumors].
    Hofstädter F
    Urologe A; 1987 Jan; 26(1):2-6. PubMed ID: 3576859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transitional cell carcinoma exhibiting clear cell features. A differential diagnosis for clear cell adenocarcinoma of the urinary tract.
    Kotliar SN; Wood CG; Schaeffer AJ; Oyasu R
    Arch Pathol Lab Med; 1995 Jan; 119(1):79-81. PubMed ID: 7802559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy and key cytologic features of high-grade transitional cell carcinoma in the upper urinary tract.
    Potts SA; Thomas PA; Cohen MB; Raab SS
    Mod Pathol; 1997 Jul; 10(7):657-62. PubMed ID: 9237174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in the Diagnosis of Urothelial Carcinoma Variants: Can Emerging Molecular Data Complement Pathology Review?
    Solomon JP; Lowenthal BM; Kader AK; Parsons JK; Flaig TW; Siefker-Radtke AO; Dyrskjøt L; Hansel DE
    Urology; 2017 Apr; 102():7-16. PubMed ID: 27769917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage systemic therapy for advanced urothelial carcinoma: on the cusp of a sea change?
    Sonpavde G; Bellmunt J
    Oncologist; 2015 May; 20(5):461-3. PubMed ID: 25845991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nested variant of transitional cell carcinoma: a neoplasm resembling proliferation of Brunn's nests.
    Murphy WM; Deana DG
    Mod Pathol; 1992 May; 5(3):240-3. PubMed ID: 1495929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing concepts on pathology and therapy for transitional cell carcinoma.
    Cummings KB
    J Urol; 1995 Nov; 154(5):1717-8. PubMed ID: 7563330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.